avatar_investigadors.jpg

Olga Ochoa Gondar

EPIVAC

ORCID: 0000-0002-7015-0018

USR Reus-Tarragona

CAP Sant Pere i Sant Pau

Medicina de Familia

Biografia

Publicacions

Real world effectiveness of antipneumococcal vaccination against pneumonia in adults: a population-based cohort study, Catalonia, 2019

C. DE DIEGO-CABANES, V. TORRAS-VIVES, A. VILA-CÓRCOLES, E. SATUÉ-GRACIA, M. FORCADELL-PERIS, F. GÓMEZ-BERTOMEU, L. DE ESTEBAN-JÚLVEZ, I. HOSPITAL-GUARDIOLA, C. FUENTES-BELLIDO, A. RIBES-ALCOVER, C. RODRIGUEZ-CASADO and O. OCHOA-GONDAR
BMC INFECTIOUS DISEASES. 2025 Oct 21; . doi:10.1186/s12879-025-11596-w; PMID:41120971

Incidence of pneumococcal and all-cause pneumonia in adults in Catalonia following the implementation of universal pneumococcal vaccination in children: 2015-2016 vs. 2017-2018.

Torras-Vives V, de Diego-Cabanes C, Satué-Gracia EM, Forcadell-Peris MJ, Ochoa-Gondar O and Vila-Córcoles Á
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2025 Aug 1; . doi:10.1016/j.eimce.2025.03.005; PMID:40157824

Classification rule for ten year MACE Risk in primary care tarragona older adults with type2 diabetes: a CHAID decision-tree analysis

D. SEGUÍ, M. FORCADELL, A. VILA-CÓRCOLES, C. DE DIEGO-CABANES, O. OCHOA-GONDAR, F. LUJAN and E. GRACIA
Bmc Primary Care. 2025 Apr 25; . doi:10.1186/s12875-025-02826-w; PMID:40281435

Evaluating Sex Differences in Pneumococcal Disease Burden and Vaccination Effectiveness in Adults: A Population-Based Study.

Forcadell-Peris MJ, Vila-Córcoles À, de Diego-Cabanes C, Torras Vives V, Ochoa-Gondar O and Satué-Gracia EM
JOURNAL OF INFECTIOUS DISEASES. 2025 Jan 7; . doi:10.1093/infdis/jiae624; PMID:39676526

Epidemiología de la neumonía neumocócica en adultos mayores de 50 años: estudio de cohortes en Cataluña, 2017-2018.

Ochoa-Gondar O, Torras-Vives V, de Diego-Cabanes C, Satué Gracia E, Forcadell-Peris MJ and Vila-Córcoles Á
ATENCION PRIMARIA. 2023 Jul 1; . doi:10.1016/j.aprim.2023.102631; PMID:37119778

Incidence and risk factors of pneumococcal pneumonia in adults: a population-based study

O. OCHOA-GONDAR, V. TORRAS-VIVES, C. DE DIEGO-CABANES, E. SATUÉ-GRACIA, A. VILA-ROVIRA, M. FORCADELL-PERISA, D. RIBAS-SEGUÍ, C. RODRÍGUEZ-CASADO and A. VILA-CÓRCOLES
BMC Pulmonary Medicine. 2023 Jun 8; . doi:10.1186/s12890-023-02497-2; PMID:37291502

Evaluating clinical effectiveness and impact of anti-pneumococcal vaccination in adults after universal childhood PCV13 implementation in Catalonia, 2017-2018

A. VILA-CORCOLES, O. OCHOA-GONDAR, C. DE DIEGO-CABANES, E. SATUE-GRACIA, V. TORRAS-VIVES, M. FORCADELL-PERIS, D. RIBAS-SEGUI, A. VILA-ROVIRA and C. RODRIGUEZ-CASADO
Vaccine: X. 2023 Apr 1; . doi:10.1016/j.jvacx.2023.100264; PMID:36798107

Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination among adults with immunocompromising conditions

E. SATUE-GRACIA, C. CABANES, A. VILA-ROVIRA, C. RODRIGUEZ-CASADO, O. OCHOA-GONDAR and A. VILA-CORCOLES
EUROPEAN RESPIRATORY JOURNAL. 2022 Sep 4; . doi:10.1183/13993003.congress-2022.263;

Evaluating pneumococcal vaccine’s effectiveness against pneumonia among adults over 50 years in Catalonia, 2017-2018

C. CABANES, A. VILA-CORCOLES, E. SATUE-GRACIA, O. OCHOA-GONDAR, A. VILA-ROVIRA and M. FORCADELL-PERIS
EUROPEAN RESPIRATORY JOURNAL. 2022 Sep 4; . doi:10.1183/13993003.congress-2022.258;

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain.

Satué-Gracia EM, Vila-Córcoles A, de Diego-Cabanes C, Vila-Rovira A, Torrente-Fraga C, Gómez-Bertomeu F, Hospital-Guardiola I, Ochoa-Gondar O and Martín-Luján F
Medicina Clinica (english Ed.). 2022 Apr 23; . doi:10.1016/j.medcle.2021.03.034; PMID:35492428

Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain

E. SATUE-GRACIA, A. VILA-COORCOLES, C. DE DIEGO-CABANES, A. VILA-ROVIRA, C. TORRENTE-FRAGA, F. GOMEZ-BERTOMEU, I. HOSPITAL-GUARDIOLA, O. OCHOA-GONDAR and F. MARTIN-LUJAN
MEDICINA CLINICA. 2022 Mar 18; . doi:10.1016/j.medcli.2021.03.027; PMID:34074472

Development of a predictive prognostic rule for early assessment of COVID-19 patients in primary care settings

A. VILA-CORCOLES, E. SATUE-GRACIA, A. VILA-ROVIRA, C. DE DIEGO-CABANES, M. FORCADELL-PERIS and O. OCHOA-GONDAR
ATENCION PRIMARIA. 2021 Nov 1; . doi:10.1016/j.aprim.2021.102118; PMID:34139400

  • Any: 01/11/2021
  • FI: 2.206
  • Article

COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort study in Southern Catalonia, Spain, March-June 2020

A. VILA-CORCOLES, E. SATUE-GRACIA, A. VILA-ROVIRA, C. DE DIEGO-CABANES, M. FORCADELL-PERIS, I. HOSPITAL-GUARDIOLA, O. OCHOA-GONDAR and J. BASORA-GALLISA
BMC PUBLIC HEALTH. 2021 Oct 6; . doi:10.1186/s12889-021-11879-2; PMID:34615512

  • Any: 06/10/2021
  • FI: 4.135
  • Article

Lugar de atención, sintomatología y curso clínico, gravedad y letalidad en 536 casos confirmados de COVID-19 en adultos mayores de 50 años en el área de Tarragona, marzo-junio de 2020.

Vila-Córcoles Á, Vila-Rovira Á, Satué-Gracia EM, Ochoa-Gondar O, de Diego-Cabanes C, Hospital-Guardiola I, Forcadell-Peris MJ, Martín-Luján F and Basora-Gallisà J
REVISTA ESPANOLA DE SALUD PUBLICA. 2021 Sep 8; PMID:34493700

  • Any: 08/09/2021
  • FI: 1.333
  • Article

ABSTRACT Treatment setting, symptomatology, clinical course, severity degree and case-fatality rate in 536 adults over 50 years with laboratory-confirmed COVID-19 in Tarragona, Spain, March-June 2020

A. VILA-CORCOLES, A. VILA-ROVIRA, E. SATUE-GRACIA, O. OCHOA-GONDAR, C. DE DIEGO-CABANES, I. HOSPITAL-GUARDIOLA, M. FORCADELL-PERIS, F. MARTIN-LUJAN and J. BASORA-GALLISA
REVISTA ESPANOLA DE SALUD PUBLICA. 2021 Sep 8;

  • Any: 08/09/2021
  • FI: 1.333
  • Article

Use of distinct anti-hypertensive drugs and risk for COVID-19 among hypertensive people: a population-based cohort study in Southern Catalonia, Spain

A. VILA-CORCOLES, E. SATUE-GRACIA, O. OCHOA-GONDAR, C. TORRENTE-FRAGA, F. GOMEZ-BERTOMEU, A. VILA-ROVIRA, I. HOSPITAL-GUARDIOLA, C. DE DIEGO-CABANES, F. BEJARANO-ROMERO, D. ROVIRA-VECIANA and J. BASORA-GALLISA
Journal of Clinical Hypertension. 2020 Aug 1; . doi:10.1111/jch.13948; PMID:32710674

  • Any: 01/08/2020
  • FI: 3.738
  • Article

Evaluation of incidence and risk profile for suffering Covid-19 infection by underlying conditions among middle-aged and older adults in Tarragona

A. VILA-CORCOLES, O. OCHOA-GONDAR, C. TORRENTE-FRAGA, A. VILA-ROVIRA, E. SATUE-GRACIA, I. HOSPITAL-GUARDIOLA, C. DE DICGO-CABANES, F. GOMEZ-BERTOMEU and J. BASORA-GALLISA
REVISTA ESPANOLA DE SALUD PUBLICA. 2020 Jun 26; PMID:32588837

  • Any: 26/06/2020
  • FI: 0.756
  • Article

Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study

A. VILA-CORCOLES, O. OCHOA-GONDAR, A. VILA-ROVIRA, M. ARAGON, L. ESTEBAN-JULVEZ, N. CHAMORRO, I. HOSPITAL, E. SATUE, J. BLADE, C. DE DIEGO, F. GOMEZ-BERTOMEU and X. RAGA
LUNG. 2020 Jun 1; . doi:10.1007/s00408-020-00349-y; PMID:32253492

  • Any: 01/06/2020
  • FI: 2.584
  • Article

Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016

A. VILA-CORCOLES, I. HOSPITAL, O. OCHOA-GONDAR, E. SATUE, C. DE DIEGO, A. VILA-ROVIRA, F. GOMEZ-BERTOMEU, X. RAGA and M. ARAGON
Vaccine. 2020 Jan 29; . doi:10.1016/j.vaccine.2019.11.012; PMID:31759735

  • Any: 29/01/2020
  • FI: 3.641
  • Article

Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain

A. VILA-CORCOLES, O. OCHOA-GONDAR, E. SATUE-GRACIA, C. TORRENTE-FRAGA, F. GOMEZ-BERTOMEU, A. VILA-ROVIRA, I. HOSPITAL-GUARDIOLA, C. DE DIEGO-CABANES, F. BEJARANO-ROMERO and J. BASORA-GALLISA
BMJ Open. 2020 Jan 1; . doi:10.1136/bmjopen-2020-041577; PMID:33303459

  • Any: 01/01/2020
  • FI: 2.692
  • Article

Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017

A. VILA-CORCOLES, O. OCHOA-GONDAR, C. DE DIEGO, E. SATUE, A. VILA-ROVIRA and M. ARAGON
Eurosurveillance. 2019 Jul 18; . doi:10.2807/1560-7917.ES.2019.24.29.1800446; PMID:31339099

  • Any: 18/07/2019
  • FI: 6.454
  • Article

Incidencia poblacional de neumonía neumocócica hospitalizada en adultos con distintos niveles de riesgo en cataluña durante 2015, estudio EPIVAC.

Vila Córcoles Á, Hospital Guardiola I, Ochoa Gondar O, Vila Rovira Á, Aragón Pérez M and Satué Gracia E
REVISTA ESPANOLA DE SALUD PUBLICA. 2019 Apr 30; PMID:31313756

  • Any: 30/04/2019
  • FI: 0.746
  • Article

Population-based incidence of hospitalised pneumococcal pneumonia in adults with distinct baseline risk strata in Catalonia throughout 2015, the EPIVAC study

A. CORCOLES, O. GONDAR, A. ROVIRA, M. PEREZ and E. GRACIA
REVISTA ESPANOLA DE SALUD PUBLICA. 2019 Apr 30;

  • Any: 30/04/2019
  • FI: 0.746
  • Article

Incidence and mortality of myocardial infarction among Catalonian older adults with and without underlying risk conditions: The CAPAMIS study

M. FORCADELL, A. VILA-CORCOLES, C. DE DIEGO, O. OCHOA-GONDAR and E. SATUE
European Journal of Preventive Cardiology. 2018 Nov 1; . doi:10.1177/2047487318788396; PMID:30019923

Antipneumococcal vaccination in Catalonian adults: Vaccine coverages and adequacy to distinct guideline recommendations

O. OCHOA-GONDAR, A. VILA-CORCOLES, C. DE DIEGO, E. SATUE, A. VILA-ROVIRA and M. ARAGON
ATENCION PRIMARIA. 2018 Nov 1; . doi:10.1016/j.aprim.2017.05.015; PMID:29373143

  • Any: 01/11/2018
  • FI: 1.346
  • Article

Epidemiología de la enfermedad neumocócica invasiva en la región de Tarragona, 2012-2015: Incidencia, letalidad y cobertura de serotipos para las distintas formulaciones vacunales antineumocócicas.

Vila Córcoles Á, Dacosta Moreira C, de Diego Cabanes C, Ochoa Gondar O, Raga Gutiérrez M, Gómez Bertomeu F, Raga Luria X and Figuerola Massana E
REVISTA ESPANOLA DE SALUD PUBLICA. 2018 Oct 2; PMID:30280720

  • Any: 02/10/2018
  • FI: 0.635
  • Article

Epidemiology of invasive pneumococcal disease in Tarragona, Spain, 2012-2015: incidence, lethality and serotype-coverage for distinct antipneumococcal vaccine formulations

A. CORCOLES, C. MOREIRA, C. CABANES, O. GONDAR, M. GUTIERREZ, F. BERTOMEU, X. LURIA and E. MASSANA
REVISTA ESPANOLA DE SALUD PUBLICA. 2018 Oct 2;

  • Any: 02/10/2018
  • FI: 0.635
  • Article

Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study

A. VILA-CORCOLES, O. OCHOA-GONDAR, C. DE DIEGO, E. SATUE, M. ARAGON, A. VILA-ROVIRA, F. GOMEZ-BERTOMEU, R. MAGAROLAS, E. FIGUEROLA-MASSANA, X. RAGA, M. PEREZ and F. BALLESTER
BMC INFECTIOUS DISEASES. 2018 Apr 27; . doi:10.1186/s12879-018-3096-7; PMID:29699550

  • Any: 27/04/2018
  • FI: 2.565
  • Article

Cobertures de vacunacions antipneumocòccica de polisacàrids i conjugada en la població catalana major de 50 anys

E. SATUÉ, O. OCHOA, A. VILA, C. DE DIEGO, I. HOSPITAL, B. GONZÁLEZ and N. ARGAZ
Butlletí De La Camfic. 2018 Jan 1;

Prevalence of high, medium and low-risk medical conditions for pneumococcal vaccination in Catalonian middle-aged and older adults: a population-based study

O. OCHOA-GONDAR, I. HOSPITAL, A. VILA-CORCOLES, M. ARAGON, M. JARIOD, C. DE DIEGO and E. SATUE
BMC PUBLIC HEALTH. 2017 Jun 29; . doi:10.1186/s12889-017-4529-8; PMID:28662648

Estimates of Target Population for Pneumococcal Vaccination in People over 50 years in Catalonia and Spain

A. VILA-CORCOLES, O. OCHOA-GONDAR, E. SATUE, M. VILA-ROVIRA and M. JARIOD
REVISTA ESPANOLA DE SALUD PUBLICA. 2017 Mar 16; PMID:28300793

Pneumococcal disease in adults: Risk levels and vaccine recommendations

A. VILA-CORCOLES and O. OCHOA-GONDAR
ATENCION PRIMARIA. 2017 Feb 1; . doi:10.1016/j.aprim.2016.06.007; PMID:27765456

  • Any: 01/02/2017
  • FI: 1.148
  • Article

Incidence and risk conditions of ischemic stroke in older adults

E. SATUE, A. VILA-CORCOLES, O. OCHOA-GONDAR, C. DE DIEGO, M. FORCADELL, T. RODRIGUEZ-BLANCO, L. BARNES and M. JARIOD
ACTA NEUROLOGICA SCANDINAVICA. 2016 Oct 1; . doi:10.1111/ane.12535; PMID:26592375

  • Any: 01/10/2016
  • FI: 3.087
  • Article

Pneumococcal pneumonia in adults 60 years or older: Incidence, mortality and prevention

A. VILA-CORCOLES, X. ANSA, O. OCHOA-GONDAR, E. SATUE, C. DE DIEGO and T. RODRIGUEZ-BLANCO
MEDICINA CLINICA. 2016 Mar 4; . doi:10.1016/j.medcli.2015.09.015; PMID:26654560

  • Any: 04/03/2016
  • FI: 1.125
  • Article

Prevalence of High-Risk Underlying Conditions for Pneumococcal Disease Among People Over 50 Years in Catalonia, Spain

E. SATUÉ, O. OCHOA, A. VILA, C. DE DIEGO, I. HOSPITAL and M. ARAGÓN
Prim Health Care. 2016 Jan 1;

Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia

A. VILA-CORCOLES, O. OCHOA-GONDAR, I. HOSPITAL, C. DE DIEGO, E. SATUE, J. BLADE, X. ANSA, J. GUZMAN, E. SALSENCH and F. RAMOS
Human Vaccines & Immunotherapeutics. 2016 Jan 1; . doi:10.1080/21645515.2016.1210744; PMID:27454779

  • Any: 01/01/2016
  • FI: 2.157
  • Article

Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: Incidence, serotype distribution and vaccine’s effectiveness

O. OCHOA-GONDAR, E. FIGUEROLA-MASSANA, A. VILA-CORCOLES, C. AGUIRRE, C. DE DIEGO, E. SATUE, F. GOMEZ and X. RAGA
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY. 2015 Dec 1; . doi:10.1016/j.ijporl.2015.09.022; PMID:26453272

  • Any: 01/12/2015
  • FI: 1.125
  • Article

Influence of chronic illnesses and underlying risk conditions on the incidence of pneumococcal pneumonia in older adults

A. VILA-CORCOLES, C. AGUIRRE-CHAVARRIA, O. OCHOA-GONDAR, C. DE DIEGO, T. RODRIGUEZ-BLANCO, F. GOMEZ, X. RAGA, L. BARNES, R. MAGAROLAS and L. ESTEBAN
INFECTION. 2015 Dec 1; . doi:10.1007/s15010-015-0801-y; PMID:26037386

  • Any: 01/12/2015
  • FI: 2.294
  • Article

Incidencia y mortalidad por infarto agudo de miocardio en la población mayor de 60 años del área de Tarragona.

Vila-Córcoles A, Forcadell MJ, de Diego C, Ochoa-Gondar O, Satué E, Rull B, Barnes L and Jariod M
REVISTA ESPANOLA DE SALUD PUBLICA. 2015 Nov 1; . doi:10.4321/S1135-57272015000600007; PMID:26786307

  • Any: 01/11/2015
  • FI: 0.693
  • Article

Incidence and lethality of invasive pneumococcal disease in Tarragona, Spain, 2006-2009

A. VILA-CORCOLES, E. SALSENCH-SERRANO, O. OCHOA-GONDAR, C. AGUIRRE-CHAVARRIA, J. UTRERA-APONTE and J. GUZMAN-AVALOS
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. 2015 Mar 1; . doi:10.1016/j.eimc.2014.09.018; PMID:25613558

Prevalence of serotypes causing invasive pneumococcal disease in the region of Tarragona, Spain, 2006-2009: vaccine-serotype coverage for the distinct antipneumococcal vaccine formulations

O. OCHOA-GONDAR, F. GOMEZ-BERTOMEU, A. VILA-CORCOLES, X. RAGA, C. AGUIRRE, J. UTRERA, C. DE DIEGO, J. GUZMAN and E. FIGUEROLA
Revista Espanola de Quimioterapia. 2015 Feb 1; PMID:25690142

  • Any: 01/02/2015
  • FI: 1.014
  • Article

Incidence and lethality of ischaemic stroke among people 60 years or older in the region of Tarragona (Spain), 2008-2011

A. VILA-CORCOLES, E. SATUE-GRACIA, O. OCHOA-GONDAR, C. DE DIEGO-CABANES, A. VILA-ROVIRA, J. BLADE, F. BOBE, R. CASANOVA, M. JARIOD and R. REIG
REVISTA DE NEUROLOGIA. 2014 Dec 1; . doi:10.33588/rn.5911.2014264; PMID:25418143

Pneumococcal conjugate vaccination: correlates of protection

A. VILA-CORCOLES and O. OCHOA-GONDAR
LANCET INFECTIOUS DISEASES. 2014 Sep 1; . doi:10.1016/S1473-3099(14)70849-7; PMID:25042757

  • Any: 01/09/2014
  • FI: 22.433
  • Article

Evaluating Clinical Effectiveness of Pneumococcal Vaccination in Preventing Stroke: The CAPAMIS Study, 3-Year Follow-up

A. VILA-CORCOLES, O. OCHOA-GONDAR, T. RODRIGUEZ-BLANCO, C. DE DIEGO-CABANES, E. SATUE-GRACIA, A. VILA-ROVIRA and C. FRAGA
Journal of Stroke & Cerebrovascular Diseases. 2014 Jul 1; . doi:10.1016/j.jstrokecerebrovasdis.2013.12.047; PMID:24656243

  • Any: 01/07/2014
  • FI: 1.669
  • Article

Validation of the CORB75 (confusion, oxygen saturation, respiratory rate, blood pressure, and age >= 75 years) as a simpler pneumonia severity rule

O. OCHOA-GONDAR, A. VILA-CORCOLES, T. RODRIGUEZ-BLANCO, I. HOSPITAL, E. SALSENCH, X. ANSA and N. SAUN
INFECTION. 2014 Apr 1; . doi:10.1007/s15010-013-0565-1; PMID:24293055

  • Any: 01/04/2014
  • FI: 2.618
  • Article

Evaluating the clinical effectiveness of pneumococcal vaccination in preventing myocardial infarction: The CAPAMIS study, three-year follow-up

O. OCHOA-GONDAR, A. VILA-CORCOLES, T. RODRIGUEZ-BLANCO, C. DE DIEGO-CABANES, I. HOSPITAL-GUARDIOLA and M. JARIOD-PAMIES
Vaccine. 2014 Jan 3; . doi:10.1016/j.vaccine.2013.11.017; PMID:24262314

  • Any: 03/01/2014
  • FI: 3.624
  • Article

Ineffectiveness of Pneumococcal Vaccination in Cardiovascular Prevention: The CAPAMIS Study

A. VILA-CORCOLES, O. OCHOA-GONDAR, T. RODRIGUEZ-BLANCO, C. DE DIEGO and E. SATUE
JAMA Internal Medicine. 2013 Nov 11; . doi:10.1001/jamainternmed.2013.6901; PMID:23712335

Preventing Pneumococcal Disease in the Elderly

A. VILA-CORCOLES and O. OCHOA-GONDAR
DRUGS & AGING. 2013 May 1; . doi:10.1007/s40266-013-0060-5; PMID:23420119

  • Any: 01/05/2013
  • FI: 2.503
  • Article

Ability of the modified CRB75 severity scale in assessing elderly patients with community acquired pneumonia

O. GONDAR, A. CORCOLES, T. BLANCO, C. CABANES and E. SERRANO
ATENCION PRIMARIA. 2013 Apr 1; . doi:10.1016/j.aprim.2012.12.005; PMID:23369644

  • Any: 01/04/2013
  • FI: 0.894
  • Article

Incidence of pneumococcal infections among children under 15 years in southern Catalonia throughout the heptavalent conjugate vaccine era, 2002-2009

A. VILA-CORCOLES, O. OCHOA-GONDAR, A. GUZMAN-AVALOS, F. GOMEZ-BERTOMEU, E. FIGUEROLA-MASSANA, X. RAGA-LURIA, C. DE DIEGO-CABANES, A. GUTIERREZ-PEREZ, A. VILA-ROVIRA and M. RODRIGUEZ-FERNANDEZ
INFECTION. 2013 Apr 1; . doi:10.1007/s15010-012-0345-3; PMID:23055151

  • Any: 01/04/2013
  • FI: 2.864
  • Article

Evolution of the Antipneumococcal Vaccination Coverage Among Children in the Region of Tarragona, Spain, 2002-2011

A. CORCOLES, O. GONDAR, A. PEREZ, C. CABANES, A. ROVIRA and B. LAMBAN
REVISTA ESPANOLA DE SALUD PUBLICA. 2012 Nov 1; PMID:23325138

  • Any: 01/11/2012
  • FI: 0.696
  • Article

Relationship between annual influenza vaccination and winter mortality in diabetic people over 65 years

A. VILA-CORCOLES, O. OCHOA-GONDAR, T. RODRIGUEZ-BLANCO, A. GUTIERREZ-PEREZ and A. VILA-ROVIRA
Human Vaccines & Immunotherapeutics. 2012 May 1; . doi:10.4161/hv.18548; PMID:22327503

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study.

Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A and Vila-Rovira A
Human Vaccines & Immunotherapeutics. 2012 May 1; . doi:10.4161/hv.19466; PMID:22634442

Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up

A. VILA-CORCOLES, O. OCHOA-GONDAR, T. RODRIGUEZ-BLANCO, A. GUTIERREZ-PEREZ, A. VILA-ROVIRA, F. GOMEZ, X. RAGA, C. DE DIEGO, E. SATUE and E. SALSENCH
BMC PUBLIC HEALTH. 2012 Mar 22; . doi:10.1186/1471-2458-12-222; PMID:22436146

  • Any: 22/03/2012
  • FI: 2.076
  • Article

Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview

A. VILA-CORCOLES and O. OCHOA-GONDAR
Expert Review of Vaccines. 2012 Feb 1; . doi:10.1586/ERV.11.176; PMID:22309670

  • Any: 01/02/2012
  • FI: 4.219
  • Article

Incidence of invasive pneumococcal disease among elderly people in Southern Catalonia, Spain, 2002-2009: An increase in serotypes not contained in the heptavalent conjugate vaccine

O. OCHOA-GONDAR and A. VILA-CORCOLES
JOURNAL OF INFECTION. 2011 Dec 1; . doi:10.1016/j.jinf.2011.08.013; PMID:21875616

  • Any: 01/12/2011
  • FI: 4.126
  • Article

Comparison of three predictive rules for assessing severity in elderly patients with CAP

O. OCHOA-GONDAR, A. VILA-CORCOLES, T. RODRIGUEZ-BLANCO, F. RAMOS, C. DE DIEGO, E. SALSENCH, D. GIL, J. DANIEL, L. PALACIOS and J. BLADE
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2011 Nov 1; . doi:10.1111/j.1742-1241.2011.02742.x; PMID:21951687

  • Any: 01/11/2011
  • FI: 2.415
  • Article

Invasive pneumococcal disease in Catalonian elderly people, 2002-2009: Serotype coverage for different anti-pneumococcal vaccine formulations at the beginning of the new conjugate vaccines era

A. VILA-CORCOLES, O. OCHOA-GONDAR, F. GOMEZ-BERTOMEU and X. RAGA-LURIA
Vaccine. 2011 Oct 6; . doi:10.1016/j.vaccine.2011.07.066; PMID:21803108

  • Any: 06/10/2011
  • FI: 3.766
  • Article

Usefulness of the CRB-65 scale for prognosis assessment of patients 65 years or older with community-acquired pneumonia

A. CORCOLES, O. GONDAR and T. BLANCO
MEDICINA CLINICA. 2010 Jun 19; . doi:10.1016/j.medcli.2009.09.049; PMID:20462613

  • Any: 19/06/2010
  • FI: 1.413
  • Article

Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

A. VILA-CORCOLES, O. OCHOA-GONDAR, J. GUZMAN, T. RODRIGUEZ-BLANCO, E. SALSENCH and C. FUENTES
BMC INFECTIOUS DISEASES. 2010 Mar 18; . doi:10.1186/1471-2334-10-73; PMID:20298596

  • Any: 18/03/2010
  • FI: 2.825
  • Article

Rationale and design of the CAPAMIS study: Effectiveness of pneumococcal vaccination against community-acquired pneumonia, acute myocardial infarction and stroke

A. VILA-CORCOLES, I. HOSPITAL-GUARDIOLA, O. OCHOA-GONDAR, C. DE DIEGO, E. SALSENCH, X. RAGA and C. FUENTES-BELLIDO
BMC PUBLIC HEALTH. 2010 Jan 19; . doi:10.1186/1471-2458-10-25; PMID:20085658

  • Any: 19/01/2010
  • FI: 2.364
  • Article

Vacunación antigripal y mortalidad invernal en pacientes diabéticos mayores de 65 años

A. VALDIVIESO, O. OCHOA, M. RODRÍGUEZ, A. VILA, V. ARIJA and C. DE DIEGO
MEDICINA DE FAMILIA-SEMERGEN. 2010 Jan 1;

Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia

A. VILA-CORCOLES, F. BEJARANO-ROMERO, E. SALSENCH, O. OCHOA-GONDAR, C. DE DIEGO, F. GOMEZ-BERTOMEU, X. RAGA-LURIA, X. CLIVILLE-GUASCH and V. ARIJA
BMC INFECTIOUS DISEASES. 2009 Mar 25; . doi:10.1186/1471-2334-9-36; PMID:19320989

Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: A matched case-control study

A. VILA-CORCOLES, E. SALSENCH, T. RODRIGUEZ-BLANCO, O. OCHOA-GONDAR, C. DE DIEGO, A. VALDIVIESO, I. HOSPITAL, F. GOMEZ-BERTOMEU and X. RAGA
Vaccine. 2009 Mar 4; . doi:10.1016/j.vaccine.2009.01.013; PMID:19171174

  • Any: 04/03/2009
  • FI: 3.616
  • Article

Incidence and Clinical Characteristics of Community-Acquired Pneumonia Managed as Outpatient among Elderly People in Tarragona-Valls, Spain

A. CORCOLES, T. BLANCO, O. GONDAR, E. SERRANO, C. CABANES and A. LOPEZ
REVISTA ESPANOLA DE SALUD PUBLICA. 2009 Mar 1; . doi:10.1590/S1135-57272009000200014; PMID:19626257

  • Any: 01/03/2009
  • FI: 0.747
  • Article

Epidemiology of community-acquired pneumonia in older adults: A population-based study

A. VILA-CORCOLES, O. OCHOA-GONDAR, T. RODRIGUEZ-BLANCO, X. RAGA-LURIA and F. GOMEZ-BERTOMEU
RESPIRATORY MEDICINE. 2009 Feb 1; . doi:10.1016/j.rmed.2008.08.006; PMID:18804355

  • Any: 01/02/2009
  • FI: 2.331
  • Article

Effects of annual influenza vaccination on winter mortality in elderly people with chronic heart disease

C. DE DIEGO, A. VILA-CORCOLES, O. OCHOA, T. RODRIGUEZ-BLANCO, E. SALSENCH, I. HOSPITAL, F. BEJARANO, M. MUNIAIN, M. FORTIN and M. CANALS
EUROPEAN HEART JOURNAL. 2009 Jan 1; . doi:10.1093/eurheartj/ehn498; PMID:18997178

The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 Study

O. OCHOA-GONDAR, A. VILA-CORCOLES, C. DE DIEGO, V. ARIJA, M. MAXENCHS, M. GRIVE, E. MARTIN and J. PINYOL
BMC PUBLIC HEALTH. 2008 Jun 27; . doi:10.1186/1471-2458-8-222; PMID:18582392

  • Any: 27/06/2008
  • FI: 2.029
  • Article

Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: Results of the EVAN-65 study

O. OCHOA-GONDAR, A. VILA-CORCOLES, X. ANSA, T. RODRIGUEZ-BLANCO, E. SALSENCH, C. DE DIEGO, X. RAGA, F. GOMEZ, E. VALDIVIESO, C. FUENTES and L. PALACIOS
Vaccine. 2008 Apr 7; . doi:10.1016/j.vaccine.2008.02.021; PMID:18343541

  • Any: 07/04/2008
  • FI: 3.298
  • Article

Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease

A. VILA-CORCOLES, O. OCHOA, C. DE DIEGO, A. VALDIVIESO, I. HERREROS, F. BOBE, M. ALVAREZ, M. JUAREZ, I. GUINEA, X. ANSA and N. SAUN
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2008 Jan 1; . doi:10.1111/j.1742-1241.2007.01414.x; PMID:17573840

  • Any: 01/01/2008
  • FI: 2.007
  • Article

Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods

A. VILA-CORCOLES, T. RODRIGUEZ, C. DE DIEGO, O. OCHOA, A. VALDIVIESO, E. SALSENCH, X. ANSA, W. BADIA and N. SAUN
Vaccine. 2007 Sep 17; . doi:10.1016/j.vaccine.2007.07.015; PMID:17698263

  • Any: 17/09/2007
  • FI: 3.377
  • Article

Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: The EVAN-65 Study

A. VILA-CORCOLES, O. OCHOA-GONDAR, I. HOSPITAL, X. ANSA, A. VILANOVA, T. RODRIGUEZ and C. LLOR
CLINICAL INFECTIOUS DISEASES. 2006 Oct 1; . doi:10.1086/507340; PMID:16941367

  • Any: 01/10/2006
  • FI: 6.186
  • Article

Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up

A. VILA-CORCOLES, O. OCHOA-GONDAR, F. ESTER, N. SARRA, X. ANSA and N. SAUN
BMC PUBLIC HEALTH. 2006 Sep 18; . doi:10.1186/1471-2458-6-231; PMID:16981982

  • Any: 18/09/2006
  • FI: 1.603
  • Article

Characteristics and predictors for non-vaccination with PPV in the elderly population

A. VILA, O. OCHOA and X. ANSA
PREVENTIVE MEDICINE. 2006 Mar 1; . doi:10.1016/j.ypmed.2005.10.008; PMID:16360832

¿Tenemos en cuenta el nivel de rieso de los pacientes para prescribir la vacuna antineumocócica?

M. NOGUERA, O. OCHOA, A. VILA, N. SAUN and F. ESTER
MEDICINA DE FAMILIA-SEMERGEN. 2006 Jan 1;

Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects

A. VILA-CORCOLES, O. OCHOA-GONDAR, C. LLOR, I. HOSPITAL, T. RODRIGUEZ and A. GOMEZ
EUROPEAN RESPIRATORY JOURNAL. 2005 Dec 1; . doi:10.1183/09031936.05.00030205; PMID:16319340

  • Any: 01/12/2005
  • FI: 3.947
  • Article

Influenza vaccination and mortality in the elderly

A. VILA-CORCOLES, O. OCHOA-GONDAR, X. ANSA-ECHEVERRIA, A. GOMEZ-SORRIBES, P. ESPELT-ALUJA and I. PASCUAL-MORON
MEDICINA CLINICA. 2005 Nov 19; . doi:10.1016/S0025-7753(05)72156-4; PMID:16324480

  • Any: 19/11/2005
  • FI: 1.074
  • Article

Incidencia de neumonía neumocócica: el sesgo de la fuentes de información

O. OCHOA and A. VILA
REVISTA ESPANOLA DE SALUD PUBLICA. 2005 Jan 1;

Methodology of observational studies of pneumococcal polysaccharide vaccine

A. CORCOLES, O. GONDAR and C. LLOR
LANCET INFECTIOUS DISEASES. 2004 Feb 1; . doi:10.1016/S1473-3099(04)00922-3; PMID:14871627

  • Any: 01/02/2004
  • FI: 10.788
  • Article

Efectividad de la vacuna antineumocócica en pacientes mayores de 65 años

M. ALVAREZ, O. OCHOA, A. VILA, I. HOSPITAL and I. GUINEA
Medifam. 2003 Jan 1;

Factors de risc per a l’aparició de pneumonia en ancians

M. ALVAREZ, M. JUAREZ, O. OCHOA, A. VILA and I. GUINEA
Butlletí De La Societat Catalana De Medicina Familiar I Comunitària. 2003 Jan 1;

Vacunació antipneumocòccica en fumadors i persones amb malaltia pulmonar obstructiva crònica

X. ANSA, O. OCHOA, A. VILA and F. GRIFOLL
Butlletí De La Societat Catalana De Medicina Familiar I Comunitària. 2003 Jan 1;

Patronat

Col·laboradors

Acreditacions